Cerebrolysin in Patients with TBI: Systematic Review and Meta-Analysis

TBI (traumatic brain injury) is one of the most common causes of deaths and failure to return to society according to the latest statistics. Cerebrolysin is a drug approved for use in patients diagnosed with TBI. It is a mixture of neuropeptides derived from purified porcine brain proteins and multi...

Full description

Bibliographic Details

Published in:	Brain Sciences
Main Authors:	Konrad Jarosz, Klaudyna Kojder, Agata Andrzejewska, Joanna Solek-Pastuszka, Anna Jurczak
Format:	Article
Language:	English
Published:	MDPI AG 2023-03-01
Subjects:	TBI Cerebrolysin neuroprotective treatment
Online Access:	https://www.mdpi.com/2076-3425/13/3/507